Clinical Studies
Living with Type 2 Diabetes? You’re not alone.
Are you or a loved one looking for a new way to help control your Type 2 Diabetes?
ReCETTM is an investigational device for Type 2 Diabetes and is being evaluated in several clinical studies.
See if you qualify.
REGENT-1 US
Location: United States
Study type: For individuals inadequately controlled on non-insulin glucose lowering medications for Type 2 Diabetes.
REGENT-1 AUS
Location: Australia
Study type: For individuals inadequately controlled on non-insulin glucose lowering medications with or without insulin for Type 2 Diabetes.
EMINENT Study
Location: Netherlands
Study type: For individuals with Type 2 Diabetes using insulin to control their glucose levels.
Email to see if you qualify
For physicians
If you are a physician or clinical provider interested in our clinical studies, please contact us.